Hypertrophic cardiomyopathy
Conditions
Interventions
Gold Standard:Cardiac Magnetic Resonance Imaging (CMR) Findings
Index test:Contrast-enhanced ultrasound (CEUS) was used to assess its diagnostic efficacy in patients with hereditary hypertrophic cardiomyopathy (HCM) when compared to the gold standard (cardiac magn
Sponsors
Zhongshan Hospital, Fudan University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18–80 years, male or female; 2. Having undergone genetic testing and confirmed as carriers of the hypertrophic cardiomyopathy gene; 3. Voluntarily participating in this study and signing an informed consent form;
Exclusion criteria
Exclusion criteria: 1. Patients with suspected or known hypersensitivity to ultrasound contrast agents; 2. Severe valvular heart disease; 3. Severe chronic obstructive pulmonary disease; 4. Patients with unstable cardiopulmonary status (worsening or unstable congestive heart failure, or severe ventricular arrhythmias); 5. Women who are breastfeeding or pregnant; 6. Individuals deemed unsuitable for participation in this trial by the investigator;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sensitivity;Specificity;Positive predictive value;Accuracy;Negative predictive value; | — |
Countries
China
Contacts
Public ContactShu Xianhong
Zhongshan Hospital, Fudan University
Outcome results
None listed